Role of nutrition in preventing cancer

Canadian Family Physician

Volumn 53, Issue 11, 2007, Pages 1905-1911

  Béliveau, Richard ^a,b   Gingras, Denis ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; PLANT MEDICINAL PRODUCT; ANTIOXIDANT;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CASE CONTROL STUDY; COHORT ANALYSIS; COLORECTAL CANCER; CORRELATION ANALYSIS; CYTOTOXICITY; DIETARY INTAKE; DIGESTIVE SYSTEM CANCER; DISEASE COURSE; EVIDENCE BASED MEDICINE; FOOD COMPOSITION; FOOD INTAKE; FRUIT; HUMAN; INFLAMMATION; MICROENVIRONMENT; NUTRITION; PRECANCER; QUALITY CONTROL; REVIEW; RISK REDUCTION; VEGETABLE; CANADA; DIET; DIET SUPPLEMENTATION; DIETARY FIBER; FEEDING BEHAVIOR; FEMALE; INCIDENCE; MALE; NEOPLASM; NUTRITIONAL ASSESSMENT; RISK FACTOR; ROLE PLAYING; SENSITIVITY AND SPECIFICITY;

ANTIOXIDANTS; CANADA; DIET; DIETARY FIBER; DIETARY SUPPLEMENTS; FEMALE; FOOD HABITS; FRUIT; HUMANS; INCIDENCE; MALE; NEOPLASMS; NUTRITION ASSESSMENT; RISK FACTORS; ROLE; SENSITIVITY AND SPECIFICITY; VEGETABLES;

EID: 38449089558     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981;66:1191-308.
2. American Institute for Cancer Research, World Cancer Research Fund. Food, nutrition, and the prevention of cancer: a global perspective. Washington, DC: American Institute for Cancer Research; 1997.
3. Willett WC. Diet and cancer. Oncologist 2002;5:393-404.
4. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, et al. Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000;343:78-85.
5. Gescher A, Pastorino U, Plummer SM, Manson MM. Suppression of tumour development by substances derived from the diet - mechanisms and clinical implications. Br J Clin Pharmacol 1998;45:1-12.
6. Thomson CA, LeWinn K, Newton TR, Alberts DS, Martinez ME. Nutrition and diet in the development of gastrointestinal cancer. Curr Oncol Rep 2003;5:192-202.
7. Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nature Rev Cancer 2003;3:768-80.
8. Dorai T, Aggarwal BB. Role of chemopreventive agents in cancer therapy. Cancer Lett 2004;215:129-40.
9. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
10. Béliveau R, Gingras D. Foods that fight cancer: preventing cancer through diet. Toronto, ON: McClelland & Stewart Ltd; 2006.
11. Black WC, Welch HG. Advances in diagnostic imaging and over-estimations of disease prevalence and the benefits of therapy. N Engl J Med 1993;328:1237-43.
12. Folkman J, Kalluri R. Cancer without disease [abstract]. Nature 2004;427:787.
13. Ames BN, Gold LS, Willett WC. The causes and prevention of cancer. Proc Natl Acad Sci USA 1995;92:5258-65.
14. Ioannides C, Lewis DF. Cytochromes P450 in the bioactivation of chemicals. Curr Top Med Chem 2004;4(16):1767-88.
15. Conney AH. Enzyme induction and dietary chemicals as approaches to cancer chemoprevention: the seventh DeWitt S. Goodman lecture. Cancer Res 2003;63:7005-31.
16. Talalay P. Chemoprotection against cancer by induction of phase 2 enzymes. Biofactors 2000;12:5-11.
17. Hecht SS. Chemoprevention of cancer by isothiocyanates, modifiers of carcinogen metabolism. J Nutr 1999;129:768S-74S.
18. Talalay P, Fahey JW. Phytochemicals from cruciferous plants protect against cancer by modulating carcinogen metabolism. J Nutr 2001;131:3027S-33S.
19. Guyonnet D, Belloir C, Suschetet M, Siess MH, Le Bon AM. Mechanisms of protection against aflatoxin B(1) genotoxicity in rats treated by organosulfur compounds from garlic. Carcinogenesis 2002;23:1335-41.
20. Hahn-Obercyger M, Stark AH, Madar Z. Grapefruit and oroblanco enhance hepatic detoxification enzymes in rats: possible role in protection against chemical carcinogenesis. J Agric Food Chem 2005;53:1828-32.
21. Thornalley PJ. Isothiocyanates: mechanism of cancer chemopreventive action. Anticancer Drugs 2002;13:331-8.
22. Karunagaran D, Rashmi R, Kumar TR. Induction of apoptosis by curcumin and its implications for cancer therapy. Curr Cancer Drug Targets 2005;5:117-29.
23. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997;275:218-20.
24. Jeon KI, Rih JK, Kim HJ, Lee YJ, Cho CH, Goldberg ID, et al. Pretreatment of indole-3-carbinol augments TRAIL-induced apoptosis in a prostate cancer cell line, LNCaP. FEBS Lett 2003;544:246-51.
25. Jung EM, Park JW, Choi KS, Park JW, Lee HI, Lee KS, et al. Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis through CHOP-independent DR5 upregulation. Carcinogenesis 2006;27:2008-17.
26. Folkman J. Angiogenesis. Annu Rev Med 2006;57:1-18.
27. Tosetti F, Ferrari N, De Flora S, Albini A. "Angioprevention": angiogenesis is a common and key target for cancer chemopreventive agents. FASEB J 2002;16(1):2-14.
28. Béliveau R, Gingras D. Green tea: prevention and treatment of cancer by nutraceuticals. Lancet 2004;364:1021-2.
29. Lamy S, Gingras D, Béliveau R. Green tea catechins inhibit vascular endothelial growth factor receptor phosphorylation. Cancer Res 2002;62:381-5.
30. Gupta S, Hastak K, Ahmad N, Lewin JS, Mukhtar H. Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc Natl Acad Sci USA 2001;98:10350-5.
31. Shanafelt TD, Lee YK, Call TG, Nowakowski GS, Dingli D, Zent CS, et al. Clinical effects of oral green tea extracts in four patients with low grade B-cell malignancies. Leuk Res 2006;30:707-12.
32. Labrecque L, Lamy S, Chapus A, Mihoubi S, Durocher Y, Cass B, et al. Combined inhibition of PDGF and VEGF receptors by ellagic acid, a dietary-derived phenolic compound. Carcinogenesis 2005;26:821-6.
33. Lamy S, Blanchette M, Michaud-Levesque J, Lafleur R, Durocher Y, Moghrabi A, et al. Delphinidin, a dietary anthocyanidin, inhibits vascular endothelial growth factor receptor-2 phosphorylation. Carcinogenesis 2006;27:989-96.
34. Bergers G, Song S, Meyer-Morse N, Bergsland E, Hanahan D. Benefits of targeting both pericytes and endothelial cells in the tumour vasculature with kinase inhibitors. J Clin Invest 2003;111:1287-95.
35. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-7.
36. Balkwill F, Charles KA, Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 2005;7:211-7.
37. Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB, et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 2000;342:1946-52.
38. Bertagnolli MM, Eagle CJ, Zauber AG, Redston N, Soloman SD, Kim K, et al. Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med 2006;355:873-84.
39. Giugliano D, Ceriello A, Esposito K. The effects of diet on inflammation: emphasis on the metabolic syndrome. J Am Coll Cardiol 2006;48:677-85.
40. Calder PC. Dietary modification of inflammation with lipids. Proc Nutr Soc 2002;61:345-58.
41. Larsson SC, Kumlin M, Ingelman-Sundberg M, Wolk A. Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am J Clin Nutr 2004;79:935-45.
42. Surh YJ, Chun KS, Cha HH, Han SS, Keum YS, Park KK, et al. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat Res 2001;480-1:243-68.
43. Aggarwal BB, Shishodia S. Suppression of the nuclear factor-kappaB activation pathway by spice-derived phytochemicals: reasoning for seasoning. Ann NY Acad Sci 2004;1030:434-41.
44. Sharma RA, Euden SA, Platton SL, Cooke DN, Shafayat A, Hewitt HR, et al. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res 2004;10:6847-54.
45. D'Incalci M, Steward WP, Gescher AJ. Use of cancer chemopreventive phytochemicals as antineoplastic agents. Lancet Oncol 2005;6:899-904.
46. Chao A, Thun MJ, Connell CJ, McCullough ML, Jacobs EJ, Flanders WD, et al. Meat consumption and risk of colorectal cancer. JAMA 2005;293:172-82.
47. Cho E, Chen WY, Hunter DJ, Stampfer MJ, Colditz GA, Hankinson SE, et al. Red meat intake and risk of breast cancer among premenopausal women. Arch Intern Med 2006;166:253-9.